Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial

BACKGROUND: Renal transplantation is the best treatment for kidney failure, in terms of length and quality of life and cost-effectiveness. However, most transplants fail after 10 to 12 years, consigning patients back onto dialysis. Damage by the immune system accounts for approximately 50% of failin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorling, Anthony, Rebollo-Mesa, Irene, Hilton, Rachel, Peacock, Janet L, Vaughan, Robert, Gardner, Leanne, Danzi, Guilherme, Baker, Richard, Clark, Brendan, Thuraisingham, Raj C, Buckland, Matthew, Picton, Michael, Martin, Susan, Borrows, Richard, Briggs, David, Horne, Robert, McCrone, Paul, Kelly, Joanna, Murphy, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906093/
https://www.ncbi.nlm.nih.gov/pubmed/24447519
http://dx.doi.org/10.1186/1745-6215-15-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906093/
https://www.ncbi.nlm.nih.gov/pubmed/24447519
http://dx.doi.org/10.1186/1745-6215-15-30

Ejemplares similares